Ngā hua rapu - Keijsers, Ruth G

In Which Patients with Sarcoidosis Is FDG PET/CT Indicated? mā Keijsers, Ruth G.M., Grutters, Jan C.

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Quantification of pulmonary disease activity in sarcoidosis measured with (18)F-FDG PET/CT: SUVmax versus total lung glycolysis mā Schimmelpennink, Milou C., Vorselaars, Adriane D. M., Veltkamp, Marcel, Keijsers, Ruth G. M.

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Volumetric FDG PET analysis of global lung inflammation: new tool for precision medicine in pulmonary sarcoidosis? mā Adams, Human, van Rooij, Rob, van Moorsel, Coline H.M., Spee-Dropkova, Marcela, Grutters, Jan C., Keijsers, Ruth G.

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Recurrent Pneumonia Due to an Appendiceal Mucinous Cystadenocarcinoma: A Rare Presentation of a Rare Malignancy mā Gerritsen, Karin G., Slee, Peter H., Bollen, Thomas L., van Hecke, Wim., Seldenrijk, Cornelis A., Keijsers, Ruth G., Duurkens, Vincent A.

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Altered splenic [(89)Zr]Zr-rituximab uptake in patients with interstitial lung disease not responding to rituximab: could this indicate a splenic immune-mediated mechanism? mā Adams, Human, Meek, Bob, van de Garde, Ewoudt MW, van Moorsel, Coline HM, Vugts, Danielle J, Keijsers, Ruth G, Grutters, Jan C

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

[(89)Zr]Zr-rituximab PET/CT activity in patients with therapy refractory interstitial pneumonitis: a feasibility study mā Adams, Human, van de Garde, Ewoudt MW, van Moorsel, Coline HM, Vugts, Danielle J, van Dongen, Guus AMS, Grutters, Jan C, Keijsers, Ruth G

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa